Connect with us

Health

Novel nanobody combinations protect cells from SARS-CoV-2 in vitro – Drug Target Review

By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.

Published

on

post featured image

Posted: 14 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Researchers have developed combined nanobodies which can neutralise SARS-CoV-2, even if it mutates. According to the team, the nanobodies could be developed a drug treatment for use in those critically ill with COVID-19, the disease caused by SARS-CoV-2, or people that may not be…

Click here to view the original article.

You might also like ...

post featured image
Coronavirus: Concerns over bosses breaking Covid safety rules – Yahoo Finance
post featured image
COVID-19 does even more damage to the lungs than smoking, doctor says – BGR
Gary Taubes: ‘Obesity isn’t a calorie problem, it’s a hormone problem’ – The Guardian